Clinical and Translational Research
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 14, 2021; 27(30): 5076-5087
Published online Aug 14, 2021. doi: 10.3748/wjg.v27.i30.5076
Table 1 Genotypic and allelic distributions of the CC chemokine ligand 4 gene polymorphism (rs10491121) in n (%), among 610 patients with colorectal cancer and 409 healthy controls
Genotype/allele
Patients
Controls
G/G(250 (41.0)176 (43.0)
G/A281 (46.1)181 (44.3)
A/A79 (12.9)52 (12.7)
G781 (64.0)533 (65.2)
A439 (36.0)285 (34.8)
Table 2 Genotypic and allelic distributions of the CC chemokine ligand 4 gene polymorphism (rs10491121) in n (%), regarding tumour location and disease stage among patients with colon cancer
Variable
Cases
Genotype


Allele

Right colonG/GG/AA/AGA
Stages I + II11638 (32.8)62 (53.4)16 (13.8)138 (59.5)94 (40.5)
Stages III + IV7844 (56.4)b24 (30.8)10 (12.8)112 (71.8)a44 (28.2)
Left colon
Stages I + II6723 (34.3)34 (50.8)10 (14.9)80 (59.7)54 (40.3)
Stages III + IV7527 (36.0)37 (49.3)11 (14.7)91 (60.7)59 (39.3)
Table 3 Genotypic and allelic distributions of the CCL4 gene polymorphism (rs10491121) in n (%), regarding non-mucinous and mucinous cancer among patients (n = 610) with colorectal cancer
Genotype/allele
Non-mucinous
Mucinous
G/G222 (42.0) 28 (34.1)
G/A247 (46.8 )34 (41.5)
A/A59 (11.2 )20 (24.4)b
G691 (65.4)90 (54.9)
A365 (34.6)74 (45.1)b
Table 4 Tissue levels and plasma levels of CC chemokine ligand 4 in colorectal cancer patients
Variable
Cases, n
CCL4 protein
Tissue
Colorectal cancer tissue98137 [5–3413] pg/mgb
Paired normal tissue9872 [5–2205] pg/mg
Plasma
Patient10363 [8–3428] pg/mLa
Control9757 [2–178] pg/mL
Table 5 Disease stage in relation to cancer tissue levels of CC chemokine ligand 4 in colorectal cancer patients
Variable
Cases, n
CCL4 protein in pg/mg
Stage
I18262 [12–3326]
II33188 [5–2797]
III22125 [24–3413]
IV2571 [10–1188]b
I + II51235 [5–3326]
III + IV4784 [10–3413]b